ENTECAVIR CRISTERS 0.5 mg, film-coated tablet 30 tablets
Active ingredients: Entecavir, Entecavir hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENTECAVIR CRISTERS 0,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes prédécoupées OPA : polyamide orienté aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Oct 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64379794CIP73010548CIP133400930105481Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ENTÉCAVIR MONOHYDRATÉcomprimé | — | SA |
| ENTÉCAVIRcomprimé | 0,50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.